Abstract
Background For over three decades, the concomitance of cortical neurodegeneration and white matter hyperintensities (WMH) has sparked discussions about their coupled temporal dynamics. Longitudinal studies supporting this hypothesis remain nonetheless scarce.
Methods In this study, we applied regional and global bivariate latent growth curve modelling (BLGCM) to longitudinal data from 436 cognitively unimpaired participants (DELCODE cohort; median age 69.70 [IQR 65.44, 74.49] years; 52.98% female) to examine the extent to which WMH and cortical thickness were interrelated over a four-year period.
Results Our findings were three-fold. First, at baseline, individuals with larger WMH volumes had lower mean cortical thicknesses over the entire brain. Second, individuals who experienced a steeper thinning of their cingulate and temporal cortices over time had larger baseline WMH volumes in the frontal, parietal, and occipital lobes. Third, individuals with thinner cortices at baseline tended to undergo faster WMH progression over four years, particularly in the occipital and parietal lobes.
Conclusions Our study suggests that cortical thinning and WMH progression could be mutually reinforcing rather than parallel, unrelated processes, which become entangled before cognitive deficits are detectable.
Trial Registration German Clinical Trials Register (DRKS00007966, 04/05/2015)
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by the German Center for Neurodegenerative Diseases (DZNE; reference number BN012) and funded by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG; Project IDs 425899996 and 362321501/RTG 2413 SynAGE; CRC 1436, projects A05, B02, B04 and C01).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All participants provided their written informed consent in accordance with the Declaration of Helsinki at baseline. DELCODE has been registered within the German Clinical Trials Register (DRKS00007966, 04/05/2015). Ethics committees of the medical faculties of all participating sites (i.e., Berlin (Charite - Universitaetsmedizin Berlin), Bonn, Cologne, Goettingen, Magdeburg, Munich (Ludwig-Maximilians-University), Rostock, and Tuebingen) approved the DELCODE study protocol before inclusion of the first participants. The ethics committee of the medical faculty of the University of Bonn led and coordinated the process.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵T Shared last authorship
We have updated the manuscript after detecting rendering problems in the previous submission.
Data Availability
The datasets used and analysed during the current study are available from the corresponding author on reasonable request.
Abbreviations
- AD
- Alzheimer’s Disease
- BLGCM
- Bivariate Latent Growth Curve Model
- CERAD
- Consortium to Establish a Registry for AD
- CFI
- Comparative Fit Index
- CI
- Confidence Interval
- CSF
- Cerebrospinal Fluid
- CSVD
- Cerebral Small Vessel Disease
- DELCODE
- DZNE Longitudinal Cognitive Impairment and Dementia Study
- DZNE
- German Centre for Neurodegenerative Diseases
- FDR
- False Discovery Rate
- HCP
- Human Connectome Project
- LGCM
- Latent Growth Curve Model
- MRI
- Magnetic Resonance Imaging
- MS
- Multiple Sclerosis
- RMSEA
- Root Mean Square Error of Approximation
- SE
- Standard Error
- SEM
- Structural Equation Model
- SRMR
- Standardised Root Mean Residual
- TICV
- Total Intracranial Volume
- WMH
- White Matter Hyperintensities
